News

• 
  Beilu's Gadopentetate Dimeglumine Injection Passed the Quality and Efficacy of Generic Drugs Consistency Evaluation

  2021/07/27

  Recently, our company received the“Drug Supplementary Application Approval Notice”(Notice Number: 2021B02267, 2021B02268) for two specifications of Gadopentetate Dimeglumine Injection.

  VIEW_MORE
• 
  Beilu Pharma's Iohexol Injection Won the Bid in the Fifth round of National Centralized Drug Procurement

  2021/06/24

  Beilu Pharma participated in the fifth round of national centralized drug procurement organized by the National Organization for Centralized Drug Procurement and Use of the Joint Procurement Office.

  VIEW_MORE
• 
  Congratulations: Beilu Pharma's Iodixanol Injection Passed the Consistency Evaluation for Generic Drugs

  2021/05/18

  Beijing Beilu Pharmaceutical Co., Ltd received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (NMPA) on Iodixanol Injection.

  VIEW_MORE
• 
  Adverse Drug Reaction (ADR) and Treatment of Major Iodinated Contrast Agents

  2021/05/06

  With the increasing application of iodinated contrast agents, the adverse reactions and risks caused by iodinated contrast agents have attracted much attention.

  VIEW_MORE
• 
  Congratulations: Beilu Pharma's Iohexol Injection Passed the Consistency Evaluation for Generic Drugs

  2021/04/21

  Recently, Beijing Beilu Pharmaceutical Co., Ltd received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (NMPA).

  VIEW_MORE
• 
  Frequently Asked Questions about Iodine Contrast Users (3)

  2021/04/15

  1. Does the iodinated contrast agent need to be preheated? Can the patient benefit from it?Preheating the iodinated contrast agent before use is recognized as the best method of application.

  VIEW_MORE
• 
  Frequently Asked Questions about Iodine Contrast Users (2)

  2021/04/15

  1. Does the allergy test of iodinated contrast agents need to be done?The allergy test of iodinated contrast agents cannot reduce the risk of adverse reactions.

  VIEW_MORE